JP2004527490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004527490A5 JP2004527490A5 JP2002567283A JP2002567283A JP2004527490A5 JP 2004527490 A5 JP2004527490 A5 JP 2004527490A5 JP 2002567283 A JP2002567283 A JP 2002567283A JP 2002567283 A JP2002567283 A JP 2002567283A JP 2004527490 A5 JP2004527490 A5 JP 2004527490A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- pharmaceutically acceptable
- promoter
- acceptable salt
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 210000004698 lymphocyte Anatomy 0.000 claims 7
- 210000000056 organ Anatomy 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 210000003734 kidney Anatomy 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 3
- 230000024924 glomerular filtration Effects 0.000 claims 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 239000003018 immunosuppressive agent Substances 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 238000011084 recovery Methods 0.000 claims 2
- 229940122739 Calcineurin inhibitor Drugs 0.000 claims 1
- 102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 claims 1
- 101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- KKGQTZUTZRNORY-UHFFFAOYSA-N fingolimod Chemical compound CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 KKGQTZUTZRNORY-UHFFFAOYSA-N 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 239000002955 immunomodulating agent Substances 0.000 claims 1
- 230000002584 immunomodulator Effects 0.000 claims 1
- 229940121354 immunomodulator Drugs 0.000 claims 1
- 229960003444 immunosuppressant agent Drugs 0.000 claims 1
- 230000001861 immunosuppressant effect Effects 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0104438A GB0104438D0 (en) | 2001-02-22 | 2001-02-22 | Organic compounds |
| GB0105000A GB0105000D0 (en) | 2001-02-28 | 2001-02-28 | Organic compounds |
| PCT/EP2002/001860 WO2002067915A1 (en) | 2001-02-22 | 2002-02-21 | Use of accelerated lymphocyte homing agents for the manufacture of a medicament for the treatment of delayed graft function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004527490A JP2004527490A (ja) | 2004-09-09 |
| JP2004527490A5 true JP2004527490A5 (enExample) | 2005-05-26 |
| JP4318921B2 JP4318921B2 (ja) | 2009-08-26 |
Family
ID=26245749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567283A Expired - Fee Related JP4318921B2 (ja) | 2001-02-22 | 2002-02-21 | 移植片の機能発現遅延の処置のための医薬の製造のためのリンパ球ホーミング促進剤の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20040087662A1 (enExample) |
| EP (1) | EP1368015B1 (enExample) |
| JP (1) | JP4318921B2 (enExample) |
| CN (1) | CN100479814C (enExample) |
| AT (1) | ATE335475T1 (enExample) |
| BR (1) | BR0207434A (enExample) |
| CA (1) | CA2435739A1 (enExample) |
| DE (1) | DE60213766T2 (enExample) |
| ES (1) | ES2267993T3 (enExample) |
| PT (1) | PT1368015E (enExample) |
| WO (1) | WO2002067915A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL158384A0 (en) * | 2001-06-08 | 2004-05-12 | Novartis Ag | Treatment or prophylaxis of insulin producing cell graft rejection |
| PL211954B1 (pl) | 2002-01-11 | 2012-07-31 | Sankyo Co | Związek, kompozycja farmaceutyczna oraz zastosowanie kompozycji farmaceutycznej |
| JP2005272453A (ja) | 2004-02-24 | 2005-10-06 | Sankyo Co Ltd | アミノアルコール化合物 |
| EP1772145B1 (en) * | 2004-07-16 | 2011-03-23 | Kyorin Pharmaceutical Co., Ltd. | Method of effectively using medicine and method concerning prevention of side effect |
| ES2615498T3 (es) * | 2004-10-12 | 2017-06-07 | Kyorin Pharmaceutical Co., Ltd. | Procedimiento para producir hidrocloruro de 2-amino-2-[2-[4-(3-benciloxifeniltio)-2-clorofenil]etil]-1,3-propanodiol |
| KR101297302B1 (ko) * | 2005-10-07 | 2013-08-19 | 교린 세이야꾸 가부시키 가이샤 | 2-아미노-1,3-프로판디올 유도체를 유효성분으로 하는간장질환 치료제 및 간장질환 치료방법 |
| TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
| PL2058317T3 (pl) * | 2006-08-08 | 2014-03-31 | Kyorin Seiyaku Kk | Aminowa pochodna estru kwasu fosforowego i modulator receptora S1P zawierający ją jako składnik aktywny |
| WO2008018447A1 (en) * | 2006-08-08 | 2008-02-14 | Kyorin Pharmaceutical Co., Ltd. | Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| JP5452237B2 (ja) | 2008-02-07 | 2014-03-26 | 杏林製薬株式会社 | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928572A (en) * | 1971-02-11 | 1975-12-23 | Ayerst Mckenna & Harrison | Myriocin and process of preparation |
| DE122011100012I1 (de) * | 1992-10-21 | 2011-10-20 | Mitsubishi Tanabe Pharma Corp | 2-Amino-1, 3-propandiolverbindung und immunosuppressium. |
| CA2213989C (en) * | 1995-12-28 | 2007-05-29 | Yoshitomi Pharmaceutical Industries Ltd. | External preparation for topical administration |
| GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| IL155065A (en) * | 1997-04-04 | 2004-01-04 | Mitsubishi Pharma Corp | History - 2 Aminopropene - 1, 3 - Diol and Pharmaceutical Preparations Containing Them |
| JPH1180026A (ja) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | 新規免疫抑制剤、その使用方法およびその同定方法 |
| IL158384A0 (en) * | 2001-06-08 | 2004-05-12 | Novartis Ag | Treatment or prophylaxis of insulin producing cell graft rejection |
-
2002
- 2002-02-21 ES ES02711877T patent/ES2267993T3/es not_active Expired - Lifetime
- 2002-02-21 CA CA002435739A patent/CA2435739A1/en not_active Abandoned
- 2002-02-21 WO PCT/EP2002/001860 patent/WO2002067915A1/en not_active Ceased
- 2002-02-21 AT AT02711877T patent/ATE335475T1/de not_active IP Right Cessation
- 2002-02-21 DE DE60213766T patent/DE60213766T2/de not_active Expired - Fee Related
- 2002-02-21 US US10/468,471 patent/US20040087662A1/en not_active Abandoned
- 2002-02-21 JP JP2002567283A patent/JP4318921B2/ja not_active Expired - Fee Related
- 2002-02-21 BR BR0207434-6A patent/BR0207434A/pt not_active IP Right Cessation
- 2002-02-21 PT PT02711877T patent/PT1368015E/pt unknown
- 2002-02-21 EP EP02711877A patent/EP1368015B1/en not_active Expired - Lifetime
- 2002-02-21 CN CNB028053958A patent/CN100479814C/zh not_active Expired - Fee Related
-
2007
- 2007-09-26 US US11/861,586 patent/US20080015261A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2327701C2 (ru) | Нуклеозидные производные и фармацевтическая композиция, обладающая антивирусной активностью в отношении hcv | |
| RU2487119C2 (ru) | Производные иминопиридина и их применение в качестве микробиоцидов | |
| JP2004527490A5 (enExample) | ||
| JP2010515731A5 (enExample) | ||
| JP2005529182A5 (enExample) | ||
| JP2016505595A5 (enExample) | ||
| WO2005095403B1 (en) | Macrocyclic compounds as inhibitors of viral replication | |
| JP2005526857A5 (enExample) | ||
| JP2007510662A5 (enExample) | ||
| JP2004531544A5 (enExample) | ||
| JP2010530881A5 (enExample) | ||
| EP1862458A3 (en) | Therapeutic agents useful for treating pain | |
| RU2011133900A (ru) | Аналоги циклоспорина для предупреждения или лечения инфекции гепатита с | |
| WO2006039668B1 (en) | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection | |
| RU2012117829A (ru) | Фосфорамидатные производные нуклеозидов | |
| EP2266981A3 (en) | Benzothiazole compounds useful as kinase inhibitors | |
| JP2009541225A5 (enExample) | ||
| WO2005030766A8 (en) | Phenyl - carboxamide compounds useful for treating pain | |
| JP2002519355A5 (enExample) | ||
| EP1815859A3 (en) | Halimide, a cytotoxic marine natural product, and derivatives thereof | |
| JP2005504111A5 (enExample) | ||
| RU99108250A (ru) | Фунгицидная композиция | |
| JP2010500962A5 (enExample) | ||
| JP2005536503A5 (enExample) | ||
| JP2004524299A5 (enExample) |